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Abstract
Objectives—Experimental studies suggest a relationship between pesticide exposure and renal 
impairment, but epidemiological evidence is limited. We evaluated the association between 
exposure to 41 specific pesticides and end-stage renal disease (ESRD) incidence in the 
Agricultural Health Study (AHS), a prospective cohort study of licensed pesticide applicators in 
Iowa and North Carolina.
Methods—Via linkage to the United States Renal Data System, we identified 320 ESRD cases 
diagnosed between enrollment (1993-1997) and December 2011 among 55,580 male licensed 
pesticide applicators. Participants provided pesticide use information via self-administered 
questionnaires. Lifetime pesticide use was defined as the product of duration and frequency of use 
and then modified by an intensity factor to account for differences in pesticide application 
practices. Cox proportional hazards models, adjusted for age and state, were used to estimate 
associations between ESRD and: 1) ordinal categories of intensity-weighted lifetime use of 41 
pesticides, 2) poisoning and high-level pesticide exposures, and 3) pesticide exposure resulting in 
a medical visit or hospitalization.
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Results—Positive exposure-response trends were observed for the herbicides alachlor, atrazine, 
metolachlor, paraquat, and pendimethalin, and the insecticide chlordane. More than one medical 
visit due to pesticide use (HR = 2.13; 95% CI: 1.17, 3.89) and hospitalization due to pesticide use 
(HR = 3.05; 95% CI: 1.67, 5.58) were significantly associated with ESRD.
Conclusions—Our findings support an association between ESRD and chronic exposure to 
specific pesticides and suggest pesticide exposures resulting in medical visits may increase the risk 
of ESRD.
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Pesticide exposure; chronic kidney disease; end-stage renal disease
Introduction
In 2011, over 600,000 United States residents were receiving treatment for end-stage renal 
disease (ESRD), a life-threatening condition requiring dialysis or kidney transplant for 
survival. Although much research has been conducted on clinical precursors to ESRD, such 
as diabetes and hypertension, research is limited on the impact of environmental and 
occupational factors. Literature on the nephrotoxic effects of pesticides in humans is 
extremely limited, and mainly comes from case reports of both fatal and non-fatal pesticide 
poisoning, which have described acute nephrotoxicity with a variety of pesticide classes. 1-5 
Most of the evidence regarding nephrotoxicity of pesticides is restricted to experimental 
animal studies. Renal damage and dysfunction has been observed in experimental animal 
studies with exposure to specific pesticides in a dose-dependent6-9 and/or exposure duration-
dependent79-11 manner. A variety of pesticide classes have been shown to cause renal 
damage and dysfunction in animals, including organophosphate, 69 organochlorine, 1012 
carbamate, 13 and pyrethroid 14 insecticides and triazine 15 and chlorophenoxy8 herbicides.
The impact of long-term pesticide exposure on human kidney function remains largely 
unknown. Generally, studies conducted in El Salvador, Nicaragua, and Sri Lanka indicate an 
elevated prevalence of chronic kidney disease among agricultural workers 16-19 compared to 
those who have never worked in agriculture, particularly among male agricultural workers20; 
pesticide exposure is postulated to be a contributor to kidney disease in these regions, but 
existing evidence has not confirmed this hypothesis. 16-18 These studies lack specificity with 
regard to pesticide type and have not been able to adequately assess the long-term effects of 
chronic low-level or acute high-level pesticide exposure on ESRD risk. To our knowledge, 
the only study to assess pesticide exposure and ESRD found self-reported work in a place 
with frequent or daily exposure to insect or plant spray to be associated with increased 
ESRD risk. 21
The Agricultural Health Study (AHS) is the largest prospective study of pesticide applicators 
in the United States. Linking the AHS to the United States Renal Data System (USRDS) 
provides a unique opportunity to evaluate the relationship between pesticide use and ESRD 
risk. Using this linkage, we evaluated associations between chronic and acute pesticide 
exposure and ESRD risk.
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Methods
Population and case definition
Details of the AHS design have been described previously.22 Briefly, the AHS recruited 
private pesticide applicators (mainly farmers) (N= 52,394) in North Carolina and Iowa and 
commercial pesticide applicators (N=4,916) in Iowa who applied for or renewed a restricted-
use pesticide license between 1993 and 1997. At the licensing facility, each pesticide 
applicator was asked to complete a brief enrollment questionnaire. Participating applicators 
were also given a packet of additional questionnaires to complete at home and mail back 
(take-home questionnaire). Approximately 82% of eligible private applicators and 47% of 
eligible commercial applicators enrolled in the study. Farmworkers were not included in the 
AHS. At enrollment, applicators provided information on lifetime pesticide use and 
pesticide use practices, demographic characteristics, lifestyle factors, farm information, and 
medical history in a self-administered questionnaire. 22 Of enrolled applicators, 44% also 
completed the take-home questionnaire with additional questions about medical history and 
pesticide use. 23 Questionnaires are available on the AHS web site: http://aghealth.nih.gov/
collaboration/questionnaires.html.
We identified ESRD cases diagnosed between study enrollment and end of follow-up 
(December 31, 2011) through linkage with the USRDS. The USRDS collects data on all 
ESRD cases in the United States through Medical Evidence Form CMS-2728, which is 
required for all new ESRD patients, regardless of Medicare eligibility. The USRDS derives 
the first ESRD service date (FSD) by taking the earliest of: a) the date of the start of dialysis 
for chronic renal failure, as reported on the Medical Evidence form, b) the date of a kidney 
transplant, or c) the date of the first Medicare dialysis claim. 24 The FSD was used to 
estimate age at ESRD diagnosis. Date of death was obtained from state mortality files and 
the National Death Index. Because the distribution of ESRD risk factors differs by gender, 
and because few applicators were female, we excluded female applicators (N= 1,562; 2.7%) 
from this analysis. We also excluded applicators under age 18 (N=127; <1.0%) and ESRD 
cases diagnosed prior to enrollment (N=42; 11.5% of cases). This left us with 55,580 
participants for analyses of enrollment questionnaire variables, and 24,565 participants for 
analyses of take-home questionnaire variables.
Exposure assessment
Information provided on the enrollment and take-home questionnaires (Phase 1) was used to 
estimate lifetime pesticide exposure. We limited these analyses to enrollment information 
because recent exposure was anticipated to have a minor impact on ESRD risk, given the 
typical decades-long progression of this disease from chronic stage 1 to ESRD, and this 
information was not available for all participants. Participants provided information on years 
of use (duration) and average days per year of use (frequency) for 22 pesticides on the 
enrollment questionnaire. Duration and frequency of use data were obtained on the take-
home questionnaire for 28 additional pesticides. For each pesticide, an intensity-weighted 
lifetime exposure metric was generated by multiplying lifetime-days of use (product of 
duration and frequency of use) by an intensity score that accounts for differences in 
exposure resulting from variation in pesticide application methods, repair of pesticide 
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application equipment, and use of personal protective equipment 25. The intensity score 
algorithm was developed using AHS-specific pesticide exposure monitoring data, in 
conjunction with expert judgment from published studies on pesticide exposure, including 
information from the Pesticide Handlers Exposure Database.25 We used intensity-weighted 
lifetime-days as our primary exposure metric. Due to the relatively small number of cases, 
we used the distribution of use among cases to create cut-points for intensity-weighted 
lifetime use of specific pesticides. For pesticides used by ≥15% of cases, we categorized 
non-zero intensity-weighted lifetime-days into tertiles with non-users as the referent group. 
For less frequently used pesticides, non-zero intensity-weighted lifetime-days of use were 
split at the median (<median vs. ≥ median), with non-users as the referent group. Analyses 
were restricted to pesticides for which there were at least 5 cases in each exposure stratum.
To assess overall pesticide use, we evaluated risk related to duration, frequency and lifetime-
days of use of any pesticide. Duration and frequency of use were categorized into three 
levels (lowest category of use (referent), > lowest category of use to the median value, and > 
median). Cumulative lifetime-days of use was categorized into quartiles.
Participant report of medical visits due to pesticide use (enrollment questionnaire), 
unusually high personal exposure to any pesticide (take-home questionnaire), and doctor-
diagnosed pesticide poisoning (take-home questionnaire) were also evaluated in relation to 
ESRD risk.
Statistical Analysis
We used Cox proportional hazards models to calculate hazard ratios for risk of ESRD, using 
age as the timescale and adjusting for state as a covariate in all models. Person-time was 
accrued from the date of study enrollment until the earliest of ESRD diagnosis, death, or the 
end of study follow-up (December 31, 2011). The proportional hazards assumption was 
evaluated for each model by entering a product term (exposure of interest * time on study) 
into each model. A product term coefficient which differed significantly from zero (chi-
square p-value <0.10) indicated a potential violation of the proportional hazards assumption.
Private and commercial applicators were analyzed together because there were too few 
ESRD cases among the latter to analyze them separately. Race and education level were 
identified as additional potential confounders through directed acyclic graph analyses 
(DAGs) and review of prior literature. Because adjustment for these factors did not 
substantially change hazard ratio estimates and power was reduced due to incomplete 
ascertainment of education and race data, we did not adjust for these factors in the final 
analyses. Though diabetes and body mass index (BMI) were associated with ESRD risk in 
this and other studies, 2627 it was unknown whether these conditions affected pesticide use, 
and it is possible that use of specific pesticides may increase the risk of diabetes and 
BMI28-31, which may be on the causal pathway to ESRD. Hazard ratio estimates obtained 
from models adjusted for diabetes and BMI were not meaningfully different from crude 
estimates; therefore, these two conditions were not included in final adjusted models. 
Hypertension was not adjusted for because it is largely asymptomatic and therefore is 
unlikely to have affected pesticide use practices. Additionally, in our study, there was no 
association between cumulative pesticide use and hypertension (data not shown).
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To assess potential confounding by other pesticides, we examined pairwise correlations 
between pesticides that were strongly (HR in any strata ≥1.5 or ≤0.65) or significantly 
associated with ESRD in single pesticide adjusted exposure-response models. For pesticides 
with a Spearman correlation coefficient ≥0.3, we constructed models with both pesticides, 
using the intensity-weighted variables included in the main analyses. For pesticides that 
were correlated with more than one pesticide, we first evaluated each pesticide pair and then 
added correlated pesticides one at a time into subsequent models. We assessed model fit 
using Akaike information criteria (AIC) and selected that with the lowest AIC as the final 
model.
To assess linear exposure-response trends in intensity-weighted lifetime use, we used within-
category medians as the score for each level of use for each chemical. Exposure–response 
trends were also evaluated for duration, frequency, and cumulative lifetime-days of use of 
any pesticide, and number of doctor visits related to pesticide use.
ESRD is the final stage of chronic kidney disease (CKD), which is often debilitating in later 
stages of the disease. Cases may have already experienced the effects of CKD prior to study 
enrollment, which could have influenced their pesticide use. If those with earlier stages of 
renal disease have reduced exposure due to modified application practices, effect estimates 
for specific pesticide use would be biased towards the null. This bias is commonly referred 
to as the healthy worker survivor effect. 32 To evaluate the potential for this effect to 
influence our findings, we repeated analyses, excluding person-time for all participants for 
the first five years after enrollment under the assumption that ESRD cases diagnosed within 
5 years following study enrollment likely had poor renal health at enrollment.
To evaluate whether patterns of association were consistent across states, we entered a 
product term for state into pesticide use models for those pesticides for which there were at 
least 5 cases in each stratum of use in both states.
We used the AHS dataset releases P1REL201209, P3REL201209.00, and 
AHSREL201304.00. All statistical analyses were done using SAS v9.3 (Cary, NC).
Results
Of the 55,580 participants eligible for analysis, 320 (308 private and 12 commercial) were 
diagnosed with ESRD over an average 15.7-year follow-up period (incidence rate: 36.6 
ESRD cases per 100,000 person-years). Among the subset of 24,565 participants who 
returned the take-home questionnaire, there were 136 cases (incidence rate: 35.1 ESRD 
cases per 100,000 person-years). ESRD incidence was significantly higher in North Carolina 
compared to Iowa, regardless of age, which follows the pattern of ESRD incidence in the 
general population.24. In age- and state-adjusted models, education level greater than high 
school and obesity at enrollment were associated with increased risk of ESRD (Table 1). 
Self-reported doctor diagnosis of diabetes, high blood pressure, and kidney disease were 
significantly associated with increased risk of ESRD. There was a suggestive but non-
significant association between pack years of cigarettes smoked and ESRD, but applicator 
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type, number of years living on a farm, and alcohol consumption at enrollment were not 
associated with ESRD risk.
More than one doctor visit due to pesticide use and hospitalization due to pesticide use were 
both significantly associated with ESRD with a significant trend observed for increasing 
number of pesticide-related doctor visits (p for trend=0.038) (Table 2). ESRD risk was not 
associated with either self-reported unusually high personal pesticide exposure or pesticide 
poisoning, though only 5 ESRD cases reported a pesticide poisoning diagnosis. No 
exposure–response relationships were observed for duration and frequency of general 
pesticide use (data not shown), or for cumulative lifetime-days of general pesticide use 
(Table 2).
In intensity-weighted cumulative use analyses, positive associations were observed primarily 
among herbicides (Table 3). ESRD risk was associated with the highest tertile of intensity-
weighted use of five herbicides: atrazine, metolachlor, alachlor, paraquat, and pendimethalin, 
compared to no use. We observed a significant (p for trend <0.05) exposure-response trend 
with increasing use levels for all of these herbicides. Although exposure-response trends 
were not seen for the herbicides petroleum oil or imazethapyr, ever use of these chemicals 
was significantly associated with risk (HR=1.63; 95% CI: 1.11, 2.41 and HR=1.46; 95% CI: 
1.08, 1.99, respectively; data not shown). The proportional hazards assumption held for all 
exposures of interest.
Among non-herbicide pesticides, ESRD risk was associated with the highest tertile of 
metalaxyl (fungicide) use (HR = 1.92; 95% CI: 1.01, 3.66), with evidence of a positive 
exposure-response trend (Table 3). Associations for the insecticides coumaphos and 
parathion (organophosphates), aldicarb (carbamate), and chlordane (organochlorine) were 
elevated (i.e. >1.6), but did not reach statistical significance. A significant positive exposure-
response trend was present for chlordane.
In analyses of correlated pesticides, we found fourteen pesticide pairs with a Spearman 
correlation coefficient ≥0.30. Adjustment for correlated pesticides resulted in reduced 
overall sample size due to missing data for each chemical. Adjusted estimates were similar 
in magnitude and direction, but were less precise. Patterns of exposure-response also did not 
change. After adjustment for correlated pesticides, the association between ESRD risk and 
the top tertile of intensity-weighted use remained significant only for pendimethalin, and the 
association became significant for chlordane (HR=1.93; 95% CI: 1.01, 3.70). Estimates for 
atrazine, alachlor, metolachlor, and aldicarb remained elevated but were no longer 
significantly associated with ESRD risk after adjustment for correlated pesticides. We did 
not observe a correlation coefficient ≥0.3 for the following pesticides: 2,4,5 T, chlorimuron 
ethyl, paraquat, petroleum oil, coumaphos, fonofos, parathion, and permethrin (for animals) 
(data not shown).
In sensitivity analysis evaluating the potential for a ‘healthy worker survivor effect’, we 
excluded 53 cases that were diagnosed with ESRD within 5 years after enrollment and 
277,900 person-years. The greatest percent reductions of case numbers were observed in the 
‘None’ use category for all pesticides. In general, associations for intensity-weighted 
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lifetime-use were in the same direction and of very similar magnitude compared to estimates 
in the main analyses. Of note, age- and state-adjusted estimates for the highest quantile of 
intensity-weighted chlordane (HR= 1.99; 95% CI: 1.07, 3.68) and coumaphos (HR=1.81, 
95% CI: 1.03, 3.17) use became significant. (Supplemental Table 1).
Results did not change substantially when we restricted analyses to private applicators (data 
not shown). Thirteen pesticides had 5 exposed cases in each exposure stratum in both states, 
and were therefore included in analyses of interaction with state. P-values for interaction 
with state were consistently > 0.10 (data not shown), suggesting no differences by state.
Discussion
To our knowledge, this is the first study to evaluate the association between ESRD risk and 
cumulative lifetime use of specific pesticides. Among pesticide applicators in the AHS, we 
found significant positive associations between intensity-weighted use of several specific 
pesticides and ESRD; excluding cases that arose within 5 years after enrollment 
strengthened some of these associations, though estimates were less precise due to the 
reduction in sample size. This is also the first epidemiological study of ESRD risk associated 
with non-fatal pesticide poisoning, acute high-level exposure, and pesticide exposure 
requiring medical attention. Participants who reported doctor visits and hospitalization due 
to pesticide use had a significantly higher risk of ESRD diagnosis compared to those who 
did not, but we did not observe increased risk with applicator report of doctor-diagnosed 
pesticide poisoning or unusually high personal pesticide exposure.
Prior published epidemiological research on pesticide exposure and kidney disease is 
minimal. Results from several cross-sectional studies evaluating the relationship between 
agricultural work and CKD suggest a potential association between agricultural work, 
particularly field work, and CKD prevalence1720. Studies that have evaluated overall 
pesticide exposure have found positive associations with CKD17183536. The only study to 
assess the relationship between ESRD risk and agricultural exposures observed an increased 
risk of ESRD among a large population of insured patients in the San Francisco Bay area 
who reported that they worked in a place with “frequent or daily exposure to insect or plant 
spray” (unadjusted hazard ratio: 1.78; 95% CI: 1.36-2.34).21 In contrast, results from our 
analyses of general overall pesticide use did not show an association with ESRD; however 
few participants in this licensed applicator cohort reported no pesticide use, and evaluation 
of overall pesticide use may obscure associations because only some pesticides appear to be 
associated with ESRD.
Epidemiologic studies of renal effects of specific pesticides are rare. Hernandez et al (2006) 
found no difference in serum creatinine levels among greenhouse workers with higher vs. 
lower levels of apparent cholinesterase inhibition (used as a marker for organophosphate 
pesticide exposure).37 Serum levels of several organochlorine insecticides among chronic 
kidney disease patients were inversely associated with kidney function, potentially 
indicating a renal filtration deficiency resulting in an accumulation of organochlorine 
pesticides in the body.38 In our study, ESRD risk was elevated for three cholinesterase-
inhibiting insecticides (the carbamate aldicarb and the organophosphates coumaphos and 
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parathion), with a moderate positive trend observed for coumaphos. No associations were 
seen with organochlorine use, except for chlordane, which was significantly positively 
associated with ESRD risk after adjustment for correlated pesticides and in analyses 
excluding cases diagnosed within five years after enrollment. Glyphosate was recently 
partially banned in Sri Lanka due to its hypothesized association with kidney disease, though 
the ban has since been lifted. Studies that informed this partial ban suggested that glyphosate 
exposure leads to renal failure only when combined with high-level exposure to heavy 
metals.39 We found no evidence of an association between ESRD risk and glyphosate 
exposure.
Experimental evidence supports our findings of positive associations with exposure to the 
herbicides atrazine, alachlor, paraquat, and pendimethalin and the fungicide metalaxyl, with 
evidence of dose-response as well as renal damage and dysfunction at low dose levels. 
Glomerular lesions and renal tubular necrosis due to oxidative stress-induced cell damage 
have been observed in animal models with exposure to metalaxyl and paraquat,4041 and 
kidney damage and dysfunction have been observed in rats exposed to atrazine 15 and fish 
exposed to alachlor.42 There have been no reports of renal effects of pendimethalin among 
mammals; however, at least one formulation of pendimethalin contains monochlorobenzene 
as an inert ingredient, which has been shown to cause kidney damage in rats.43 Although we 
observed a positive exposure-response trend for metolachlor, we found no published studies 
implicating this chemical in renal dysfunction or oxidative stress pathways. Sub-acute 
tubulointerstitial and glomerular damage, such as that observed in animal studies with 
prolonged low dosing of pesticides, 711 can initiate a feed-forward loop of kidney injury and 
progressive loss of renal function. 44 In humans, pesticide poisoning can lead to acute kidney 
injury,45 which has been associated with increased risk of subsequent chronic kidney disease 
and ESRD. 4647
When we adjusted for correlated pesticides, we found that estimates for atrazine, alachlor, 
metolachlor, and aldicarb were positively associated but no longer statistically significant. 
We lacked power to formally test interaction among specific pesticides. In addition, we saw 
significant associations for chemicals from a number of chemical groups. Given that there is 
no required renal toxicity testing for pesticides, we have no information regarding which 
chemicals we would expect to be associated with CKD. A large portion of commercial 
pesticide products are “other ingredients” including solvents; therefore, it is possible that 
one or more of these “other ingredients” are driving the risk observed here for unrelated 
chemicals. Unfortunately, we do not have access to what these “other ingredients” are 
because they are regarded as confidential business information.
A significant positive exposure-response trend was observed for pesticide-related doctor 
visits, and participants who reported being hospitalized due to pesticide use had three times 
the risk of ESRD compared to those who did not. Though information about the route and 
type of pesticide involved in these exposures was not available, these findings support the 
hypothesis that frequent and/or severe pesticide exposures may increase the risk of ESRD. 
We did not see an association between pesticide poisoning or self-reported unusually high 
pesticide exposure and ESRD; however, power to detect an association was limited because 
information for those exposures was available only for participants who returned the take-
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home questionnaire, and pesticide poisoning was rarely diagnosed in the cohort. Pesticide 
poisoning is frequently under-diagnosed 48; thus, doctor visits or hospitalization related to 
pesticide use may represent a more sensitive indicator for acute high-level exposure than 
pesticide poisoning diagnosis.
The study improves upon prior research in several ways. First, we were able to evaluate 
associations of ESRD risk with a wide range of specific chemicals that vary in toxicity and 
extent of use. The prospective design of the study mitigates concerns about differential 
misclassification of exposure. Whereas prior studies were limited by small sample size and 
exposure to few chemicals, the large size of the AHS cohort allowed us to assess exposure-
response trends for many individual pesticides. Also, use of a validated exposure-intensity 
metric 25 allowed for a better estimate of each participant's likely pesticide exposure as 
opposed to non-specific pesticide use. Until now, the relationship between short-term high-
level pesticide exposures and kidney disease has been evaluated only with respect to the 
immediate effects of pesticide poisonings. Here, we were able to evaluate measures of non-
poisoning short-term high-level pesticide exposures, thereby providing an important 
contribution to the scientific literature regarding occupational risk factors for kidney disease. 
Additionally, the fact that almost all ESRD cases in the United States are captured in the 
USRDS reduces concerns about loss to follow-up or outcome misclassification.
Because exposure data were collected prior to disease onset and ESRD diagnosis data were 
obtained from a third party linkage rather than participant report, any exposure 
misclassification due to self-report is likely to be non-differential with respect to the 
outcome, which would bias estimates towards the null. Additionally, evidence suggests that 
report of pesticide exposure by AHS participants is reasonably reliable 49 and plausible. 50 
The accuracy and reliability of reporting acute pesticide exposures has not been investigated.
Analyses of lifetime use of pesticides that were assessed only on the take-home 
questionnaire could be subject to selection bias if applicators who returned the take-home 
questionnaire were significantly different from those who did not by exposure or outcome, 
or by factors associated with the exposure or the outcome. State of enrollment, age, and 
pesticide use characteristics were similar for those who returned the take-home 
questionnaire compared to those who did not, and the percentage of cases was essentially the 
same for take-home questionnaire respondents as it was for non-respondents (0.59% vs. 
0.57%). Still, differences in unmeasured factors remain a possibility, and we had limited 
power to evaluate associations between ESRD and lifetime use of the pesticides for which 
duration and frequency information was collected only on the take-home questionnaire.
Lifetime use estimates could also be biased if participants with prevalent pre-end stage 
kidney disease modified their pesticide application practices in the period prior to 
enrollment. This ‘healthy worker survivor effect’ is a common problem in occupational 
health studies, including among pesticide applicators, 51 frequently biasing estimates toward 
the null. 32 Results of our sensitivity analysis suggest a minimal impact of this potential 
effect on HR estimates. The median time from enrollment to ESRD diagnosis was 9.7 years. 
It is possible that unmeasured post-enrollment pesticide use may differ by case status; if 
recent exposures are stronger contributors to ESRD risk than pre-enrollment exposures, then 
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our results would still be biased towards the null. However, progression of renal disease 
from chronic stage 1 to ESRD can take several decades; if pesticide use does contribute to 
kidney disease incidence, it is probable that this pathway would have been initiated prior to 
enrollment.
Because the AHS is a cohort of US farmers in NC and IA, the risks for this cohort may be 
different from the risks experienced by farmworkers in the US or elsewhere. However, the 
AHS, with its detailed exposure characterization, limited loss to follow up over 20 years, and 
the ability to link to a population-based kidney disease registry, provides important human 
data for evaluation of the role of pesticides and kidney disease.
Lastly, in these analyses we estimated associations between a large number of exposures and 
ESRD. We did not employ statistical methods to adjust for multiple comparisons, such as the 
Bonferroni correction. Previous authors have cautioned against employing Bonferroni-type 
corrections in an epidemiological analysis of associations between multiple environmental 
or occupational exposures and disease, 52-54 and such methods have largely fallen out of use 
in such settings because Bonferroni adjustments are concerned with testing of a general null 
hypothesis which is rarely of interest. Alternatives to Bonferroni methods exist for inference 
in settings where multiple exposure effects are estimated, including Bayesian methods;55 
however, we have not employed such methods here, in preference for simply describing 
what statistical quantities have been estimated.
Conclusions
Our study provides evidence for an association between ESRD risk and chronic exposure to 
specific chemicals among pesticide applicators in Iowa and North Carolina. Results from 
this study also suggest that pesticide exposures resulting in medical visits increase the risk of 
incident ESRD, raising concerns that multiple high-level pesticide exposures may contribute 
to irreversible kidney damage and resultant disease. Efforts to better characterize the 
pathway between pesticide exposure and kidney disease should include assessments of 
earlier disease stages, rate of progression from CKD to ESRD, and other potential routes of 
pesticide exposure, such as spray drift and carry-home exposures. Caution should be taken 
in interpreting results of such studies when diagnosis dates or disease severity information is 
not available, because the healthy worker survivor effect may bias estimates towards the 
null. Additional epidemiological studies are needed to confirm the findings of our study, 
given the limited research on the role of pesticide exposure in the development of renal 
disease, and research on the direct renal toxicity of specific chemicals must be expanded to 
facilitate interpretation of epidemiological results.
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What this paper adds
• Much is known about clinical risk factors for end-stage renal disease (chronic 
kidney disease requiring dialysis or kidney transplant for survival), but 
research on environmental risk factors for kidney disease is limited.
• In this study of male pesticide applicators, risk of end-stage renal disease 
increased with increasing cumulative exposure to several pesticides, including 
the herbicides metolachlor, paraquat and pendimethalin, and the insecticide 
chlordane.
• Risk of end-stage renal disease was significantly greater for pesticide 
applicators who reported multiple doctor visits due to pesticide use and 
hospitalization due to pesticide use, compared to those who reported no 
medical visits due to pesticide use.
• Exposure to certain pesticides may increase the risk of end-stage renal 
disease; however, additional studies are needed to support these findings.
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Table 1
Association between ESRD and demographic and medical conditions among private and 
commercial applicators, adjusted for age and state, Agricultural Health Study 
(1993-1997)
Variable (at enrollment) Non-cases (N= 55,260) N (%)
ESRD Cases 
(N=320) N (%) HR (95% CI)
State (where enrolled)* Iowa 35943 (65.0) 134 (41.9)
North Carolina 19317 (35.0) 186 (58.1) 2.02 (1.61, 2.53)
Applicator type* Private 50575 (91.5) 308 (96.3)
Commercial 4685 (8.5) 12 (3.7) 0.75 (0.42, 1.35)
Age category (years) 18-30 6306 (11.4) 12 (3.8)
31-49 27380 (49.6) 58 (18.1) 1.15 (0.62, 2.15)
50-69 18924 (34.3) 210 (65.6) 6.04 (3.38, 10.81)
≥ 70 2650 (4.8) 40 (12.5) 10.04 (5.25, 19.20)
Race White 52763 (97.3) 273 (85.3)
non-White 1440 (2.7) 47 (14.7) 4.42 (3.18, 6.13)
Education level High school or less 22452 (41.7) 74 (24.3)
More than high school 31369 (58.3) 231 (75.7) 1.49 (1.14 1.95)
Number years lived or worked on a farm† 0-20 2181 (10.0) 10 (7.9)
21-30 2928 (13.4) 13 (10.2) 1.43 (0.62 3.28)
>30 16668 (76.5) 104 (81.9) 0.90 (0.46 1.75)
Number of days per month drink alcohol in the last 
year
0 16504 (31.9) 147 (52.1)
1-23 31833 (61.5) 121 (42.9) 0.86 (0.66 1.11)
≥24 3447 (6.7) 14 (5.0) 0.78 (0.45 1.36)
Number of pack-years smoked None 28059 (53.8) 124 (43.5)
1-11 10956 (21.0) 45 (15.8) 0.80 (0.57 1.13)
12-30 8708 (16.7) 67 (23.5) 1.23 (0.91 1.66)
>30 4464 (8.6) 49 (17.2) 1.36 (0.97 1.91)
Body mass index (kg/m2) <25 9658 (25.5) 44 (19.8)
25-29.99 19341 (51.1) 108 (48.6) 1.26 (0.89 1.79)
≥30 8823 (23.3) 70 (31.5) 2.00 (1.37 2.93)
Self-reported doctor diagnosis of:
Diabetes No 49616 (97.2) 192 (70.1)
Yes 1411 (2.8) 82 (29.9) 8.78 (6.72, 11.45)
High Blood Pressure† No 20081 (83.6) 52 (39.4)
Yes 3945 (16.4) 80 (60.6) 4.66 (3.25, 6.68)
Kidney disease (not counting kidney stones) No 50935 (99.2) 245 (88.4)
Yes 415 (0.8) 32 (11.6) 10.35 (7.14, 15.02)
ESRD = end-stage renal disease.
*Adjusted for age only.
†
Reported on the take-home questionnaire only
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